Fundraising Fox
🦊/People
Sign in

Andreas Halner

Founder

Founder and Head of Healthcare AI at ​ OxCan (Oxford Cancer Analytics)

Beaconsfield, England, United Kingdom

Founded​ OxCan (Oxford Cancer Analytics)

Find your path to Andreas

13 people in our graph share verified history with Andreas — schools, employers, funds. One of them is your warm intro.

Roy LobbunlockedAndreas: together at University of Oxford (1968–1970)
×7Andreas: together at University of Oxford
×2Andreas: together at ​ OxCan (Oxford Cancer Analytics)
×2Andreas: together at Zentiva

About

Andreas Halner is Chairman of OXcan (Oxford Cancer Analytics), a company focused on early cancer detection through liquid biopsy and the application of AI and machine learning. He has held executive and non-executive roles across the pharmaceutical and healthcare sector, including at GSK (SmithKline Beecham), Recordati, and Pharmakodex, and served as Senior Independent Director at Zentiva during its $2.6bn sale to sanofi-aventis. He founded and led the e-Health company OnMedica as CEO, is Founder Investor and Chairman of live-in care business EnViva Care Ltd, and serves as Chairman of the healthcare charity Project HOPE UK.

Founder and Head of Healthcare AI at ​ OxCan (Oxford Cancer Analytics)

Intro paths

→

In turn, Andreas can intro founders to ​ OxCan (Oxford Cancer Analytics)'s investors below.

​ OxCan (Oxford Cancer Analytics)'s investors · 8

Civilization Ventures Management, LlcTiburon · $1M – $10M checksCross-Border Impact VenturesToronto · $2M – $10M checksDigitalDx VenturesMenlo ParkEka VenturesLondon · $635K – $3.8M checksMeridian Health VenturesLondonOnstageLondonOxford Technology ManagementOxford · $200K – $400K checksUK Innovation & Science Seed FundLondon · $127K – $635K checks

Experience

  1. OXcan (Oxford Cancer Analytics)Chairmancurrent2021 — presentOxford, UK
  2. EnViva CareChairman2009 — 2019
  3. Project HOPE UKChairman1994 — 2015London
  4. ZentivaSenior Independent Non Exec Director2001 — 2009Prague and Amsterdam
  5. OnMedicaChief Executive2001 — 2006Clerkenwell, London and Amersham, Bucks
  6. RecordatiChairman, International1996 — 2000Switzerland
  7. GSK (SmithKlineBeecham)President & CEO1990 — 1996London, UK
  8. GSK (SmithKlineBeecham)President, Europe1972 — 1996Brentford, London, UK
  9. SmithKline Beecham/LusoFarmacoVice President & Managing Director1986 — 1990Lisbon, Portugal

Skills & more

Interpersonal SkillsStrategic ThinkingPublic Speaking2Strategic Planning11Leadership18Team Leadership4Strategy15Strategic PartnershipsE-CommerceGo-to-Market StrategyBusiness PlanningLeadership Development
+12 moreInternational MarketingEntrepreneurshipCoachingHealthcareBusiness StrategyNonprofitsMarketing StrategyTeam BuildingFundraisingSocial MediaNew Business DevelopmentStart-ups

Languages English · French · Portuguese

From Andreas's professional profile.

Frequently asked questions

Who is Andreas Halner?
Andreas Halner is Chairman of OXcan (Oxford Cancer Analytics), a company focused on early cancer detection through liquid biopsy and the application of AI and machine learning. He has held executive and non-executive roles across the pharmaceutical and healthcare sector, including at GSK (SmithKline Beecham), Recordati, and Pharmakodex, and served as Senior Independent Director at Zentiva during its $2.6bn sale to sanofi-aventis. He founded and led the e-Health company OnMedica as CEO, is Founder Investor and Chairman of live-in care business EnViva Care Ltd, and serves as Chairman of the healthcare charity Project HOPE UK.
Where does Andreas Halner work?
Andreas Halner is Founder and Head of Healthcare AI of ​ OxCan (Oxford Cancer Analytics).
What companies did Andreas Halner found?
Andreas Halner founded ​ OxCan (Oxford Cancer Analytics).
Where did Andreas Halner go to school?
Andreas Halner studied at Jesus College, University of Oxford (Master of Arts (MA), Geography); Finchley Grammar School; University of Oxford (Master of Arts (MA), Geography & Economics).

Founder mafias

Same school

Shared employers